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Abstract
Background: The presence of multiple chronic conditions is associated with lower health related quality
of life (HRQOL). Disease severity also influences HRQOL. To analyse the effects of all possible
combinations of single diseases along with their severity on HRQOL seems cumbersome. Grouping
diseases and their severity in specific organ domains may facilitate the study of the complex relationship
between multiple chronic conditions and HRQOL. The goal of this study was to analyse impaired organ
domains that affect the most HRQOL of patients with multiple chronic conditions in primary care and their
possible interactions.
Methods: We analysed data from 238 patients recruited from the clientele of 21 family physicians. We
classified all chronic conditions along with the measure of their severity into the 14 organ domains of the
Cumulative Illness Rating Scale (CIRS). Patients also completed the 36-item Medical Outcomes Study
questionnaire (SF-36). One-way analyses of variance were performed to study the relationship between
the severity score for each CIRS domain and both physical component summary (PCS) and mental
component summary (MCS) of HRQOL. Two-way analyses of variance were conducted to investigate the
significance of possible organ domains interactions. Variables involved in significant bivariate relationships
or interactions were candidates for inclusion in a multivariate model. Five additional variables were
included in the multivariate model because of their possible confounding effect: perceived social support,
age, education, perceived economic status and residual CIRS.
Results: Significant differences in the PCS (p < 0.01) were found in 12 of the 14 CIRS organ domains. A
significant difference in MCS was found only in the Psychiatric domain. In the multivariate analysis for the
PCS, the CIRS domains Musculoskeletal, Neurological, and Psychiatric, had an independent direct impact
on PCS while the Upper gastrointestinal, Vascular, Cardiac and Respiratory domains were involved in
interactions. A multivariate model was not necessary for the mental component.
Conclusion: Vascular, Upper gastrointestinal and Musculoskeletal systems have strong negative effects
on HRQOL. Among combinations of systems, the respiratory and cardiac combination is of particular
concern because of a synergistic negative effect. This study paves the way for a future study with a bigger
sample that could yield a model of wider generalizability.
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Goals of caring for patients with a chronic condition are
to enhance their functional status, minimize symptoms,
control pain, reduce disability, and prolong life through
secondary prevention [1]. Patients with multiple chronic
conditions or multimorbidity are the rule rather than the
exception in primary care [2]. For family physicians to
pursue the same care goals for patients with multimorbid-
ity, they have to develop a partnership with patients and
set priorities to address patients' health care needs with
the aim of increasing their life span while maintaining an
optimal quality of life [3,4].
Health-related quality of life (HRQOL) provides a multi-
dimensional perspective that encompasses a patient's
physical, emotional, and social functioning [5]. In gen-
eral, patients with more than one comorbid condition
report the poorest level of HRQOL [6], but some chronic
conditions are more strongly associated with poor
HRQOL than others. The severity of the individual condi-
tions is also a factor influencing HRQOL[6]. Knowledge
of the conditions that potentially have a greater impact on
the HRQOL may help family physicians focus their atten-
tion on those conditions. The combined influence of pairs
of chronic medical conditions on HRQOL have received
some attention, [7-10] but patients with multimorbidity
often present more than two chronic medical conditions
and have often multiple body systems involved [2].
Disease interactions known to affect HRQOL include,
among others, diabetes with hypertension, heart disease,
arthritis, obesity and respiratory problems; arthritis with
heart disease, hypertension, pulmonary diseases and
obesity [7-10]. To make an analysis using individually all
possible chronic conditions, their possible combinations
and effects on the HRQOL seems cumbersome. Grouping
diseases and their severity in specific organ domains may
facilitate the understanding of the complex relationship
between multiple chronic conditions and HRQOL. We
used the Cumulative Illness Rating Scale (CIRS) in a pre-
vious study to document the association between HRQOL
and multimorbidity (presence of two or more chronic
conditions). We showed that the CIRS was a better predic-
tor of HRQOL than a simple count of chronic diseases [6].
The CIRS is a comprehensive comorbidity index which
takes into account the severity of the conditions using a
scoring mechanism that encompasses 14 anatomical
domains (Cardiac, Vascular, Hematological, Respiratory,
Ophtalmological-ORL, Upper gastrointestinal, Lower gas-
trointestinal, Hepatic-pancreatic, Renal, Genitourinary,
Musculoskeletal-tegumental, Neurological, Endocrine-
metabolic-breast, and Psychiatric) [11-14]. The total CIRS
score is the sum of severity scores assigned to each organ
domain. So far, we have only used the total CIRS score in
our studies [6,15,16]. We hypothesize that the individual
organ domain score may further our understanding of the
complex relationship between multimorbidity and
HRQOL.
The goal of this study was therefore to analyse which
impaired organ domains affect the most HRQOL of
patients with multiple chronic conditions in primary care
and their possible interactions.
Methods
We used data collected in a group of 238 adult primary
care patients (age 18 or older) recruited from the clientele
of 21 family physicians in the Saguenay region, Canada,
who participated in a study on HRQOL [6]. Details of the
selection process are described elsewhere [6]. In brief, we
randomly selected patients from 980 patients who had
also been selected at random for a prevalence study on
multimorbidity [2]. Our goal was to recruit patients to
complete five CIRS groups (quintiles) of 60 patients each
with different levels of multimorbidity. Of the 419
patients we tried to contact by phone, 66 could not be
reached, despite repeated attempts. Of the remaining 353
patients, 238 agreed to participate (participation rate of
67%). Patients who refused to participate did not have
time (66 patients), or were not interested (42 patients); 7
patients were judged to be in an acute state of illness and
were not included.
From an exhaustive chart review, we extracted a compre-
hensive list of diagnoses of all chronic conditions for
every patient after informed consent. For this review, the
information contained in the medical chart was consid-
ered valid and complete. We then scored the Cumulative
Illness Rating Scale (CIRS) [17].
Each domain of the CIRS is scored from 0 to 4 as follows:
0, no problem; 1, minor current problem or significant
history; 2, morbidity or moderate discomfort, requiring
treatment; 3, severe problem, constant significant discom-
fort, chronic problem difficult to control; 4, extremely
severe problem, requiring immediate treatment, organ
failure or severe functional impairment. The theoretical
score ranges from 0 to 56, but scores close to the highest
value are incompatible with life. The CIRS has been
shown to be valid and reliable for its use in primary care
[18].
Patients completed the French version of the self-admin-
istered 36-item short form of the Medical Outcomes Study
questionnaire (SF-36) that is well known and validated to
assess HRQOL [19]. The SF-36 comprises 8 multi-item
scales divided into 2 main groups: physical and mental
aspects of quality of life. Two summary scores for each
group are obtained through a weighted sum of these
scales. For all scales and both summary scales, lowerPage 2 of 8
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physical component summary (PCS) and the mental
component summary (MCS) in the analyses.
Data for potential confounders (age, education, self-per-
ceived economic status and self-perceived social support)
were also collected. Self-perceived social support was
measured with the Social Provisions Scale [20].
The research ethics board of the Centre de santé et de serv-
ices sociaux de Chicoutimi approved this study.
Statistical analysis
Characteristics of the participants were first summarized
using means and standard deviations or percentages. We
then examined the proportion of subjects falling into each
severity level for the 14 domains covered by the CIRS.
Severity levels with low prevalence (less than 10 subjects)
were combined with the adjacent level for subsequent
analyses.
For each domain of the CIRS, one-way analyses of vari-
ance (ANOVA) were first performed to study the relation-
ship between severity and both physical (PCS) and
mental (MCS) components of quality of life, ignoring the
effect of other domains. Severity levels with non signifi-
cant differences in quality of life were combined. Two-way
analyses of variance were conducted to investigate the sig-
nificance of possible interactions based on disease interac-
tions previously identified in the literature [7-10] or in our
practice. The CIRS domains included in the analysis of
interactions for the PCS were: Cardiac, Vascular, Respira-
tory, Upper gastrointestinal, Musculoskeletal, Neurologi-
cal, Endocrine. Variables involved in bivariate
relationships or interactions significant at the 0.15 level
were candidates for inclusion in a multivariate model.
Five additional variables were included in the multivariate
model because of their possible confounding effect: per-
ceived social support, age, education, perceived economic
status and residual CIRS [6]. The latter was defined as the
sum of severity scores for the systems excluded from the
model. A backward elimination procedure was then
applied to eliminate variables which cease to be statisti-
cally significant (p > 0.05) in the presence of others. How-
ever, variables with a significant interaction term were
kept in the model, regardless of their significance level to
ensure the hierarchy principle. Analyses were performed
with SAS (SAS Institute Inc., Cary, NC), version 8.02.
Results
Characteristics of the 238 participants are reported else-
where [6]. On average, participants were 59.0 ± 14.3 years
old (mean ± SD), had 5.3 ± 2.8 diagnoses and a CIRS
score of 10.3 ± 5.7; 29% were male. Summary scores of SF-
36 were 42.22 ± 12.28 and 50.37 ± 10.21 for the physical
(PCS) and mental (MCS) components respectively. Figure
1 shows the proportion of each severity level for the 14
domains covered by the CIRS. Due to the small number of
subjects, we combined the "extremely severe" CIRS cate-
gory with the "severe" CIRS category.
Results from the bivariate analyses of the 14 domains of
the CIRS with the PCS are shown in Table 1. Significant
differences in the PCS among CIRS severity categories (p
< 0.01) were found in 12 CIRS domains. Among these
domains, only 2 subgroups of disease severity could be
differentiated according to the PCS in 9 CIRS domains.
Three subgroups of disease severity could be differentiated
in the 3 remaining CIRS domains (Respiratory, Muscu-
loskeletal and Endocrine).
In the analyses of interactions, only 2 were significant: the
Cardiac-Respiratory and the Vascular-Upper gastrointesti-
nal. Details are shown in Table 2.
In the bivariate analyses of the 14 domains of the CIRS
with the MCS, a significant difference in MCS was found
only between 2 severity subgroups in the Psychiatric
domain: no problem/mild/moderate vs. severe (p <
0.001, η2 = 6.54%). Therefore, a multivariate model was
not necessary for the mental component.
Results from the multivariate analysis for the PCS are
shown in Table 3. The CIRS domains Musculoskeletal,
Neurological, and Psychiatric, have an independent direct
impact on PCS while the Upper gastrointestinal, Vascular,
Percentage of sample in each severity levelFigure 1
Percentage of sample in each severity level. The per-
centage of sample in each severity level is shown for the 14 
domains covered by the CIRS. It should be noted that The 
CIRS assigns a value from 0 to 4 to determine a severity 
score for each domain (0 = no problem; 1 = mild; 2 = mod-
erate; 3 = severe; 4 = extremely severe). Due to the small 
number of subjects, we combined the "extremely severe" 
CIRS category with the "severe" category.Page 3 of 8
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tions. The chronic conditions most commonly found in
these domains were, respectively: stomach or duodenal
ulcers and gastro-oesophageal reflux; hypertension; coro-
nary artery disease and chronic heart failure; chronic
obstructive pulmonary disease and asthma. The coeffi-
cients in Table 3 allow calculation of an estimate of the
PCS for subjects with different problems. For example, for
a subject with no problems in the musculoskeletal, neuro-
logical and vascular domains and no or mild problems in
the psychiatric and upper gastrointestinal domains, the
PCS for moderate or severe respiratory problem and
severe cardiac problem can be estimated as:
PCS = 54.62 + (-3.11) + (-1.85) + (-8.85) = 40.8
For subjects with no problems in the musculoskeletal and
neurological domains, no or mild problems in the psychi-
atric and respiratory domains and no severe cardiac prob-
lems, the PCS for moderate or severe upper
Table 1: Relationship between the physical component summary (PCS) of SF-36 and severity of problems in each domain of the CIRS
Degrees of severity by domain of CIRS PCS (mean ± sd) p value η2
Cardiac
No problem/Mild/Moderate 43.2 ± 11.8 0.0004 5.19%
Severe 39.2 ± 12.9
Vascular
No problem 46.7 ± 11.4 <0.0001 10.83%
Mild/Moderate/Severe 38.6 ± 11.8
Haematological
No problem 42.7 ± 12.1 0.1221 1.01%
Mild/Moderate/Severe 39.2 ± 12.9
Respiratory
No problem/Mild 44.7 ± 11.7 <0.0001 12.14%
Moderate 37.5 ± 10.9
Severe 31.2 ± 12.4
Ophthalmologic and ORL
No problem/Mild 43.4 ± 12.1 0.0013 4.32%
Moderate/Severe 36.5 ± 11.6
Upper gastrointestinal
No problem/Mild 44.3 ± 11.6 <0.0001 9.17%
Moderate/Severe 35.7 ± 12.2
Lower gastrointestinal
No problem/Mild 43.4 ± 12.1 0.0050 3.30%
Moderate/Severe 38.1 ± 12.2
Hepatic and pancreatic
No problem 42.9 ± 11.8 0.1483 0.89%
Mild/Moderate 40.3 ± 13.3
Renal
No problem/Mild 42.6 ± 12.2 0.0457 1.69%
Moderate/Severe 35.6 ± 12.3
Genitourinary
No problem 44.5 ± 12.2 0.0101 2.78%
Mild/Moderate/Severe 40.4 ± 12.1
Musculoskeletal
No problem 48.8 ± 9.2 <0.0001 16.44%
Mild/Moderate 42.0 ± 12.2
Severe 34.6 ± 11.2
Neurological
No problem 44.5 ± 11.6 <0.0001 9.72%
Mild/Moderate/Severe 35.9 ± 11.9
Endocrine, metabolic, breast
No problem/Mild 44.8 ± 11.6 0.0014 5.44%
Moderate 41.3 ± 11.9
Severe 33.9 ± 14.8
Psychiatric
No problem/Mild 44.5 ± 11.6 <0.0001 6.58%
Moderate/Severe 37.9 ± 12.4Page 4 of 8
(page number not for citation purposes)
Health and Quality of Life Outcomes 2007, 5:52 http://www.hqlo.com/content/5/1/52gastrointestinal problem and mild, moderate or severe
vascular problem can be estimated as:
PCS = 54.62 + (-8.98) + (-6.58) + (+8.08) = 47.1
Graphical displays of these interactions are shown in Fig-
ures 2 and 3.
Discussion
In the present study, we have been able to develop a mul-
tivariate model relating the physical aspect of HRQOL (as
measured by the PCS of the SF-36) and all chronic condi-
tions – grouped by body systems – of patients with multi-
morbidity, while taking into account the degree of severity
of the health impairments evaluated with the CIRS.
Although small in size, this is the first study evaluating the
impact of systems involvement and their combination on
HRQOL.
The summary scales PCS and MCS were chosen to repre-
sent HRQOL in this study because they have been shown
to be among the most valid SF-36 scales for measuring
physical health and mental health, respectively [21]. Also,
confidence intervals around individual scores are much
smaller for the two summary measures than for the eight
scales (+/- 6–7 points versus +/- 13–32 points, respec-
tively) [21].
In our multivariate model, all variables have a different
weight on the resultant PCS. Impairments in all the CIRS
domains that remained in the multivariate model have a
negative coefficient (Table 3). This means that, according
to the model, these impairments have a negative impact
on PCS. The impairment with the highest direct impact
was severe Musculoskeletal problem reducing PCS by 8
points (Table 3). This latter result is consistent with
reports associating musculoskeletal disorders with large
losses of HRQOL [22,23]. This is also congruent with the
clinical experience of family doctors. Diseases included in
the musculoskeletal system are any form of arthritis,
chronic low back pain and any rheumatologic or ortho-
paedic chronic problems.
Table 3: Reduced multivariate model for the physical component summary (PCS) of the SF-36
Variable Parameter Estimate Standard error p value
Intercept 54.62 1.42 <0.0001
Mild or moderate Musculoskeletal problem (Mus1,2) -3.77 1.53 0.0145
Severe Musculoskeletal problem (Mus3,4) -8.11 1.92 <0.0001
Mild, moderate or severe Neurological problem (Neu1,2,3,4) -3.84 1.50 0.0111
Moderate or severe Psychiatric problem (Psy2,3,4) -4.06 1.40 0.0041
Severe Cardiac problem (Car3,4) -1.85 2.83 0.5142†
Moderate or severe Respiratory problem (Res2,3,4) -3.11 1.62 0.0564†
Car3,4 and Res2,3,4 -8.85 4.07 0.0307
Moderate or severe Upper gastrointestinal problem (Upg2,3,4) -8.98 2.47 0.0003
Mild, moderate or severe Vascular problem (Vas1,2,3,4) -6.58 1.49 <0.0001
Upg2,3,4 and Vas1,2,3,4 +8.08 3.10 0.0097
† kept in the model because involved in an interaction
Table 2: Significant results of the analysis of interactions among CIRS domains
Interaction PCS (mean ± sd) p value η2
Cardiac – Respiratory
Low cardiac† and low respiratory‡ 44.8 ± 11.5 <0.0001 14.99%
Severe cardiac and low respiratory‡ 43.4 ± 13.4
Low cardiac† and high respiratory§ 38.4 ± 11.2
Severe cardiac and high respiratory§ 27.0 ± 8.0
Vascular – Upper gastrointestinal
No vascular and low upper gastro‡ 49.2 ± 9.3 <0.0001 20.12%
Vascular¥ and low upper gastro‡ 39.9 ± 11.7
No vascular and high upper gastro§ 36.1 ± 13.5
Vascular¥ and high upper gastro§ 35.5 ± 11.6
† No problem, mild or moderate problem
‡ No problem or mild problem
§ Moderate or severe
¥ Mild, moderate or severePage 5 of 8
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effect of each condition approximates their combined
effect), the combined influence of pairs of chronic condi-
tions on the HRQOL can also be synergistic (the com-
bined effect is greater than the sum of the independent
effect of each condition) or subtractive (the combined
effect is smaller than the sum of the independent effect of
each condition) [7-10,24].
We found a synergistic effect between respiratory and car-
diac systems which replicates results previously reported
by Rijken et al.[10]. They found that patients with cardio-
vascular disease reported equal levels of PCS as patients
with other chronic diseases considered in their study.
However, patients with respiratory disease reported worse
PCS than patients with other chronic disease, and the
combination of cardiovascular and respiratory diseases
had a negative synergistic effect on the PCS [10]. Our data
confirm the same synergistic effect of these systems on
PCS since, in our multivariate model, cardiac problems
are not significant, respiratory problems only approach
significance and their interaction is highly significant i.e.
their combined effect decreases more the PCS than the
sum of the independent negative effect of each condition.
This is congruent with what we see in our clinical practice.
A possible explanation is the common shortness of breath
that is present when both systems are involved.
We found a subtractive interaction between moderate or
severe Upper gastrointestinal problem and mild, moder-
ate or severe Vascular problem. The independent effect of
each condition is quite important in reducing physical
functioning, but their combined effect is smaller than the
sum of the independent effects (Figure 3). We cannot pro-
vide a logical explanation for this finding. This will have
to be confirmed and explored in more details.
The literature reports other additive and synergistic inter-
actions of pairs of diseases such as diabetes-hypertension
(Endocrine-Vascular domains in the CIRS), diabetes-heart
disease (Endocrine-Heart), diabetes-arthritis (Endocrine-
Musculoskeletal) and arthritis-respiratory disease (Muscu-
loskeletal-Respiratory) that were not found to be signifi-
cant in our analysis of interactions by CIRS domains [7-
10,24]. Chronic conditions in CIRS domains or interac-
tions not included in the reduced multivariate model
should not be interpreted as domains in which health
problems do not have an impact on HRQOL or that those
interactions are not important for individual patients. It
only means that the affected domains and their interac-
tions included in the model are those with a greater
impact on the physical functioning in the sample of sub-
jects of this study.
It is worth noting that the Psychiatric domain of the CIRS
remained significant in the multivariate model for the
physical functioning. Whereas this domain is frequently
excluded from studies relating comorbidity or multimor-
bidity with HRQOL [25], our results highlight its impor-
tance in such studies and are in agreement with those
reported by Rijken et al.[10].
Rijken et al. also assessed the joint effects of a limited
number of somatic chronic diseases and found that, in
general, the MCS was not related to any of the diseases
evaluated with the exception of a negative effect of thyroid
dysfunction [10]. In our study, the bivariate analysis
Illustration of the interaction between Upper gastrointestinal and V scular CIRS domainsFigu e 3
Illustration of the interaction between Upper gas-
trointestinal and Vascular CIRS domains. The figure 
illustrates the interaction between Upper gastrointestinal and 
Vascular CIRS domains for subjects with no problems in the 
musculoskeletal and neurological domains, no or mild prob-
lems in the psychiatric and respiratory domains and no 
severe cardiac problems.
Illustration of the interaction between Cardiac and Respira-tory CIRS domainsFigu e 2
Illustration of the interaction between Cardiac and 
Respiratory CIRS domains. The figure illustrates the 
interaction between Cardiac and Respiratory domains for 
subjects with no problems in the musculoskeletal, neurologi-
cal and vascular domains and no or mild problems in the psy-
chiatric and upper gastrointestinal domains.Page 6 of 8
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the Psychiatric domain. As we evaluated the levels of
severity, we found that the significant difference was at the
"Severe" level.
Knowledge of the estimates of the relative impact of indi-
vidual chronic diseases on HRQOL is important for deci-
sion-makers to better plan and allocate resources for
research, training and health care [4]. For the primary care
physician, for whom multimorbidity implies a list of
health problems, the knowledge of specific systems or
their combinations that have a greater impact on the
patient's HRQOL is essential for individual patient care
and can be helpful to establish priorities in management
decisions [24]. Given that patients with multimorbidity
represent the majority in primary care, this knowledge is
also important for public health purposes.
This study was based on the analysis of an existing data-
base, and its main limitation is the relatively small sample
of subjects. This limitation is directly related to the effect
of the intentional sampling process to recruit patients that
represented five CIRS groups, each with different levels of
multimorbidity. This sampling process by itself was not
expected to affect the relationships in our analyses but
produced its effect through the size of the sample we
obtained. The number of subjects per severity level varied
considerably. This forced us to group subjects with prob-
lems of different levels of severity. Also, a number of dis-
eases within the CIRS domains may not be represented. A
bigger sample would have given more power to the statis-
tical analyses and any application of the multivariate
model at its present state should be made with caution.
Another limitation of the study is that the list of diagnosis
was based on chart review of all diagnoses already made
by the primary care physician and no attempt was made
to assess whether the diagnoses were correct. This method
has the limitation that conditions frequently misdiag-
nosed such as asthma and chronic obstructive pulmonary
disease, or frequently undiagnosed such as mental disor-
ders were not verified. Due to all the limitations listed
above, we consider that any generalizability of the model
at its present state should be made with caution. It might
be applicable only to the primary care clientele of our
region.
Unlike previous studies, we did not analyze the combined
effects from a pre-determined list of diseases; instead, we
included in the corresponding CIRS domains all the
chronic conditions found in the subjects. This approach is
pragmatic and directly in line with clinical practice. Nev-
ertheless, the combined influence of more than two
chronic conditions pertaining to more than two systems
on the HRQOL can be expected to be more complex than
that of a pair of diseases and consequently, caution is
mandatory in the interpretation of the study results.
Conclusion
With this study we have demonstrated the feasibility of
developing a multivariate model for the physical func-
tioning aspect of the HRQOL applicable to patients with
multimorbidity that takes into account all the chronic dis-
eases (grouped by organ domains) and their level of sever-
ity, while controlling for age, education, perceived social
support and economic status. Simple disease count as a
measure of multimorbidity has a weak correlation with
HRQOL; grouping diseases by organ domains which take
into account disease severity is a practical alternative to
consider individually each condition and its severity. Vas-
cular, Upper gastrointestinal and Musculoskeletal systems
have strong negative effects on HRQOL. Among combina-
tions of systems, the respiratory and cardiac combination
is of particular concern because of a synergistic negative
effect. This study paves the way for a future study with a
bigger sample that could yield a model of wider generaliz-
ability.
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